{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:22:41Z","timestamp":1787750561384,"version":"build-2784847793"},"reference-count":53,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jtim-2026-0061_s_008\">\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>Ferroptosis is an iron-dependent form of programmed cell death, and its dysregulation has been implicated in the progression of breast cancer (BC). Prominin 2 (PROM2) has been reported as a negative regulator of ferroptosis. This study aims to investigate the role of PROM2 in BC progression and its underlying molecular mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jtim-2026-0061_s_009\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bioinformatics analysis was performed to evaluate the expression and prognostic relevance of PROM2 in BC cohort from public database. The expression levels of PROM2 were assessed in BC tissues and cell lines. Knockdown of PROM2 was achieved using lentiviral-mediated shRNA, and the effect of PROM2 silencing in the tumor growth was evaluated in a xenograft model of nude mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jtim-2026-0061_s_010\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results demonstrated that PROM2 was overexpressed in BC tissues and its heightened expression was associated with poor prognosis. Knockdown of PROM2 in BC cell lines suppressed cell proliferation, migration, and invasion, while promoting ferroptosis, as evidenced by increased levels of reactive oxygen species (ROS), lipid peroxidation, and malondialdehyde, as well as decreased levels of glutathione and GPX4 expression. Furthermore, PROM2 was found to activate the mitogen-activated protein kinase (MAPK) signaling pathway, and inhibition of this pathway abrogated the pro-tumorigenic effects of PROM2 overexpression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jtim-2026-0061_s_011\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our findings pinpoint a crucial role of PROM2 in BC progression by inhibiting ferroptosis and activating the MAPK signaling pathway. Targeting PROM2 might represent a potential therapeutic strategy for BC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jtim-2026-0061","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:05:00Z","timestamp":1782140700000},"page":"630-646","source":"Crossref","is-referenced-by-count":0,"title":["Prominin 2 promotes the progression of breast cancer by inhibiting ferroptosis\n                    <i>via<\/i>\n                    MAPK signaling"],"prefix":"10.1515","volume":"14","author":[{"given":"Mingchuan","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6148-9186","authenticated-orcid":false,"given":"Xichun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"},{"name":"Department of Medical Oncology, Fudan University Shanghai Cancer Center , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-6940","authenticated-orcid":false,"given":"Hongxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai , China"},{"name":"Department of Medical Oncology, Fudan University Shanghai Cancer Center , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026082612595936470_j_jtim-2026-0061_ref_001","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-249.","DOI":"10.3322\/caac.21660"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_002","doi-asserted-by":"crossref","unstructured":"Malhotra GK, Zhao X, Band H, Band V. Histological, molecular and functional subtypes of breast cancers. Cancer Biol Ther 2010;10:955-960.","DOI":"10.4161\/cbt.10.10.13879"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_003","doi-asserted-by":"crossref","unstructured":"Huang P, Li F, Li L, You Y, Luo S, Dong Z, et al. lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells. Sci Rep 2018;8:17970.","DOI":"10.1038\/s41598-018-36231-4"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_004","doi-asserted-by":"crossref","unstructured":"Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA 2019;321:288-300.","DOI":"10.1001\/jama.2018.19323"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_005","doi-asserted-by":"crossref","unstructured":"Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys 2015;72:333-338.","DOI":"10.1007\/s12013-014-0459-6"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_006","doi-asserted-by":"crossref","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer 2021;124:13-26.","DOI":"10.1038\/s41416-020-01161-4"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_007","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12-49.","DOI":"10.3322\/caac.21820"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_008","doi-asserted-by":"crossref","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet 2024;286-287:18-24.","DOI":"10.1016\/j.cancergen.2024.06.002"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_009","doi-asserted-by":"crossref","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;149:1060-1072.","DOI":"10.1016\/j.cell.2012.03.042"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_010","doi-asserted-by":"crossref","unstructured":"Gaschler MM, Andia AA, Liu H, Csuka JM, Hurlocker B, Vaiana CA, et al. FINO(2) initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol 2018;14:507-515.","DOI":"10.1038\/s41589-018-0031-6"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_011","doi-asserted-by":"crossref","unstructured":"Huang L, McClatchy DB, Maher P, Liang Z, Diedrich JK, Soriano-Castell D, et al. Intracellular amyloid toxicity induces oxytosis\/ferroptosis regulated cell death. Cell Death Dis 2020;11:828.","DOI":"10.1038\/s41419-020-03020-9"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_012","doi-asserted-by":"crossref","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 2022;22:381-396.","DOI":"10.1038\/s41568-022-00459-0"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_013","doi-asserted-by":"crossref","unstructured":"Wang H, Cheng Y, Mao C, Liu S, Xiao D, Huang J, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther 2021;29:2185-2208.","DOI":"10.1016\/j.ymthe.2021.03.022"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_014","doi-asserted-by":"crossref","unstructured":"Nagpal A, Redvers RP, Ling X, Ayton S, Fuentes M, Tavancheh E, et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+ve) breast cancer metastasis. Breast Cancer Res 2019;21:94.","DOI":"10.1186\/s13058-019-1177-1"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_015","doi-asserted-by":"crossref","unstructured":"Li J, He D, Li S, Xiao J, Zhu Z. Ferroptosis: the emerging player in remodeling triple-negative breast cancer. Front Immunol 2023;14:1284057.","DOI":"10.3389\/fimmu.2023.1284057"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_016","doi-asserted-by":"crossref","unstructured":"Khan M, Sunkara V, Yadav M, Bokhari SFH, Rehman A, Maheen A, et al. Ferroptosis and Triple-Negative Breast Cancer: A Systematic Overview of Prognostic Insights and Therapeutic Potential. Cureus 2024;16:e51719.","DOI":"10.7759\/cureus.51719"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_017","doi-asserted-by":"crossref","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 2017;13:91-98.","DOI":"10.1038\/nchembio.2239"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_018","doi-asserted-by":"crossref","unstructured":"Liu H, Tang T. MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification. Sci Rep 2023;13:19055.","DOI":"10.1038\/s41598-023-45774-0"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_019","doi-asserted-by":"crossref","unstructured":"Brown CW, Amante JJ, Chhoy P, Elaimy AL, Liu H, Zhu LJ, et al. Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export. Dev Cell 2019;51:575-586.e4.","DOI":"10.1016\/j.devcel.2019.10.007"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_020","doi-asserted-by":"crossref","unstructured":"Saha SK, Islam SMR, Kwak KS, Rahman MS, Cho SG. PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Ther 2020;27:147-167.","DOI":"10.1038\/s41417-019-0109-7"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_021","doi-asserted-by":"crossref","unstructured":"Brown CW, Chhoy P, Mukhopadhyay D, Karner ER, Mercurio AM. Targeting prominin2 transcription to overcome ferroptosis resistance in cancer. EMBO Mol Med 2021;13:e13792.","DOI":"10.15252\/emmm.202013792"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_022","doi-asserted-by":"crossref","unstructured":"Wu KL, Chang CY, Tsai YM, Lai JC, Hung JY, Lin YS, et al. PROM2 up-regulation promotes cancer cell migration and confers a poor prognosis in lung squamous cell carcinoma. Am J Cancer Res 2024;14:1561-1576.","DOI":"10.62347\/EQFY1219"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_023","doi-asserted-by":"crossref","unstructured":"Johnson JA, Moore BJ, Syrnioti G, Eden CM, Wright D, Newman LA. Landmark Series: The Cancer Genome Atlas and the Study of Breast Cancer Disparities. Ann Surg Oncol 2023;30:6427-6440.","DOI":"10.1245\/s10434-023-13866-w"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_024","doi-asserted-by":"crossref","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol 2018;1711:243-259.","DOI":"10.1007\/978-1-4939-7493-1_12"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_025","doi-asserted-by":"crossref","unstructured":"Shrestha B, Dunn L. The Declaration of Helsinki on Medical Research involving Human Subjects: A Review of Seventh Revision. J Nepal Health Res Counc 2020;17:548-552.","DOI":"10.33314\/jnhrc.v17i4.1042"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_026","doi-asserted-by":"crossref","unstructured":"Li L, Liu ZP. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models. J Transl Med 2021;19:514.","DOI":"10.1186\/s12967-021-03180-y"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_027","doi-asserted-by":"crossref","unstructured":"Zeng W, Li F, Jin S, Ho PC, Liu PS, Xie X. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming. J Exp Clin Cancer Res 2023;42:245.","DOI":"10.1186\/s13046-023-02832-9"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_028","doi-asserted-by":"crossref","unstructured":"Aponte-L\u00f3pez A, Mu\u00f1oz-Cruz S. Mast Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1273:159-173.","DOI":"10.1007\/978-3-030-49270-0_9"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_029","doi-asserted-by":"crossref","unstructured":"Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res 2018;8:1483-1507.","DOI":"10.1007\/s13346-018-0551-3"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_030","doi-asserted-by":"crossref","unstructured":"Liu H. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma. Cancer Genet 2023;274-275:21-25.","DOI":"10.1016\/j.cancergen.2023.03.002"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_031","doi-asserted-by":"crossref","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol 2022;12:952290.","DOI":"10.3389\/fonc.2022.952290"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_032","doi-asserted-by":"crossref","unstructured":"Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res 2022;12:4074-4081.","DOI":"10.3389\/fonc.2022.952290"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_033","doi-asserted-by":"crossref","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet 2023;278-279:91-103.","DOI":"10.1016\/j.cancergen.2023.10.001"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_034","doi-asserted-by":"crossref","unstructured":"Li W, Zhu Y, Zhang K, Yu X, Lin H, Wu W, Peng Y, et al. PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Exp Mol Med 2020;52:409-422.","DOI":"10.1038\/s12276-020-0390-4"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_035","doi-asserted-by":"crossref","unstructured":"Tang J, Shu D, Fang Z, Yang G. Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor. Radiol Oncol 2023;57:325-336.","DOI":"10.2478\/raon-2023-0033"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_036","doi-asserted-by":"crossref","unstructured":"Kudo I, Esumi M, Kusumi Y, Furusaka T, Oshima T. Particular gene up-regulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma. Oncol Lett 2017;14:4633-4640.]","DOI":"10.3892\/ol.2017.6751"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_037","unstructured":"Uqaili AA, Usman G, Bhatti U, Nasir H, Zia R, Akram MA, et al. Bioinformatics, RNA sequencing, and targeted bisulfite sequencing analyses identify the role of PROM2 as a diagnostic and prognostic biomarker. Am J Transl Res 2023;15:5389-5407."},{"key":"2026082612595936470_j_jtim-2026-0061_ref_038","doi-asserted-by":"crossref","unstructured":"Paris J, Wilhelm C, Lebb\u00e9 C, Elmallah M, Pamoukdjian F, H\u00e9raud A, et al. PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers. Clin Transl Med 2024;14:e1632.","DOI":"10.1002\/ctm2.1632"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_039","doi-asserted-by":"crossref","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 2020;20:662-680.","DOI":"10.1038\/s41568-020-0285-7"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_040","doi-asserted-by":"crossref","unstructured":"Sui S, An X, Xu C, Li Z, Hua Y, Huang G, et al. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Theranostics 2020;10:11938-11949.","DOI":"10.7150\/thno.49451"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_041","doi-asserted-by":"crossref","unstructured":"Van Berckelaer C, Rypens C, van Dam P, Pouillon L, Parizel M, Schats KA, et al. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression. Breast Cancer Res 2019;21:28.","DOI":"10.1186\/s13058-019-1108-1"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_042","doi-asserted-by":"crossref","unstructured":"Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer 2024;10:407-416.","DOI":"10.1016\/j.trecan.2024.01.013"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_043","doi-asserted-by":"crossref","unstructured":"Zhai X, Lin Y, Zhu L, Wang Y, Zhang J, Liu J, et al. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications. Cytokine Growth Factor Rev 2024;75:101-109.","DOI":"10.1016\/j.cytogfr.2023.08.004"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_044","doi-asserted-by":"crossref","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab 2021;33:1001-1012.e5.","DOI":"10.1016\/j.cmet.2021.02.015"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_045","doi-asserted-by":"crossref","unstructured":"Liu H, Dong A, Rasteh AM, Wang P, Weng J. Identification of the novel exhausted T cell CD8 + markers in breast cancer. Sci Rep 2024;14:19142.","DOI":"10.1038\/s41598-024-70184-1"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_046","doi-asserted-by":"crossref","unstructured":"Agmon E, Solon J, Bassereau P, Stockwell BR. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties. Sci Rep 2018;8:5155.","DOI":"10.1038\/s41598-018-23408-0"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_047","doi-asserted-by":"crossref","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 2017;171:273-285.","DOI":"10.1016\/j.cell.2017.09.021"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_048","doi-asserted-by":"crossref","unstructured":"Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y, et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis 2021;12:1043.","DOI":"10.1038\/s41419-021-04296-1"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_049","doi-asserted-by":"crossref","unstructured":"Kudaravalli S, den Hollander P, Mani SA. Role of p38 MAP kinase in cancer stem cells and metastasis. Oncogene 2022;41:3177-3185.","DOI":"10.1038\/s41388-022-02329-3"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_050","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Lim\u00f3n A, Joaquin M, Caballero M, Posas F, de Nadal E. The p38 Pathway: From Biology to Cancer Therapy. Int J Mol Sci 2020;21:1913.","DOI":"10.3390\/ijms21061913"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_051","doi-asserted-by":"crossref","unstructured":"Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 2019;18:26.","DOI":"10.1186\/s12943-019-0954-x"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_052","doi-asserted-by":"crossref","unstructured":"Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, et al. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 2001;229:163-175.","DOI":"10.1006\/dbio.2000.9961"},{"key":"2026082612595936470_j_jtim-2026-0061_ref_053","doi-asserted-by":"crossref","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 2021;6:425.","DOI":"10.1038\/s41392-021-00828-5"}],"container-title":["Journal of Translational Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0061\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0061\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:00:41Z","timestamp":1787749241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jtim-2026-0061\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,26]]},"published-print":{"date-parts":[[2026,8,26]]}},"alternative-id":["10.1515\/jtim-2026-0061"],"URL":"https:\/\/doi.org\/10.1515\/jtim-2026-0061","relation":{},"ISSN":["2224-4018"],"issn-type":[{"value":"2224-4018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}